{"id":"pregabalin-capsule","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Dizziness"},{"rate":"15-25","effect":"Somnolence"},{"rate":"5-10","effect":"Dry mouth"},{"rate":"5-10","effect":"Edema"},{"rate":"5-10","effect":"Weight gain"},{"rate":"5-10","effect":"Blurred vision"},{"rate":"5-10","effect":"Ataxia"}]},"_chembl":{"chemblId":"CHEMBL1059","moleculeType":"Small molecule","molecularWeight":"159.23"},"_dailymed":{"setId":"7d93359c-1849-430d-a922-21d42932d0f3","title":"PREGABALIN CAPSULES, CV CAPSULE [CIPLA USA INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By binding to presynaptic calcium channels, pregabalin decreases calcium influx and subsequently reduces the release of glutamate, norepinephrine, and substance P. This leads to reduced neuronal excitability and pain signal transmission. The drug is effective for neuropathic pain, epilepsy, and anxiety disorders through this mechanism of action.","oneSentence":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:56.987Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury pain)"},{"name":"Partial-onset seizures (adjunctive therapy)"},{"name":"Generalized anxiety disorder"},{"name":"Fibromyalgia"}]},"trialDetails":[{"nctId":"NCT06619860","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-18","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":300},{"nctId":"NCT07377721","phase":"PHASE1","title":"A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain","status":"NOT_YET_RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-02","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":168},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT05995535","phase":"PHASE2","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-01-01","conditions":"Opiate Withdrawal Syndrome, Opioid Use","enrollment":150},{"nctId":"NCT06628908","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-01","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":1100},{"nctId":"NCT07344467","phase":"NA","title":"Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-01-17","conditions":"Oral, Melatonin, Pregabalin","enrollment":105},{"nctId":"NCT04862845","phase":"PHASE1","title":"Combination of Duloxetine and Pregabalin to Improve Postoperative Pain","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-07-30","conditions":"Postoperative Pain","enrollment":90},{"nctId":"NCT07186751","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-20","conditions":"Fibromyalgia, Pregabalin, Venlafaxine","enrollment":750},{"nctId":"NCT06833203","phase":"NA","title":"Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-12-01","conditions":"Amantadine, Pregabalin, Post-thoracotomy Pain Syndrome","enrollment":60},{"nctId":"NCT06790537","phase":"PHASE4","title":"Efficacy of Pregabalin for Diabetic Pruritus - A Randomized Controlled Study.","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-04-17","conditions":"Diabetic Pruritus, Efficacy of Pregabalin in Controlling Diabetic Pruritus Severity","enrollment":46},{"nctId":"NCT07313111","phase":"PHASE4","title":"Thymoquinone as an add-on Therapy for the Management of Patients With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2024-07-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":50},{"nctId":"NCT06715462","phase":"PHASE3","title":"Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Painful Diabetic Peripheral Neuropathy (PDPN)","enrollment":""},{"nctId":"NCT06614322","phase":"PHASE2","title":"SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-01","conditions":"Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":190},{"nctId":"NCT07275762","phase":"PHASE2","title":"Y-4 to Treat the Postherpetic Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2026-01-01","conditions":"Postherpetic Neuralgia, Y-4, Pregabalin","enrollment":160},{"nctId":"NCT03216187","phase":"PHASE3","title":"Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery","status":"TERMINATED","sponsor":"Benno Rehberg-Klug","startDate":"2018-01-09","conditions":"Persistent Postoperative Pain","enrollment":126},{"nctId":"NCT07000201","phase":"NA","title":"Preoperative Pregabalin vs Gabapentin in Elderly Undergoing Surgry,Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-09-15","conditions":"Anxiety, Anxiety Disorder (Panic Disorder or GAD)","enrollment":84},{"nctId":"NCT05660538","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-12-20","conditions":"Diabetic Peripheral Neuropathy","enrollment":194},{"nctId":"NCT05640453","phase":"PHASE4","title":"Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting","status":"RECRUITING","sponsor":"Tanta University","startDate":"2022-12-15","conditions":"Pregabalin, Delirium Treatment, Coronary Artery Bypass Grafting","enrollment":70},{"nctId":"NCT06150898","phase":"PHASE2","title":"Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2025-05-12","conditions":"Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer","enrollment":112},{"nctId":"NCT06766916","phase":"PHASE2","title":"Crisugabalin for Radiotherapy-Related Neuropathic Pain","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-05-07","conditions":"Neuropathic Pain","enrollment":172},{"nctId":"NCT06935721","phase":"PHASE1","title":"Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-28","conditions":"Healthy Male and Female Subjects","enrollment":10},{"nctId":"NCT06420778","phase":"NA","title":"The Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With Electroacupuncture","status":"RECRUITING","sponsor":"Zhejiang Chinese Medical University","startDate":"2024-07-12","conditions":"Postherpetic Neuralgia, Electroacupuncture, Infrared Thermography","enrollment":124},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT05935059","phase":"NA","title":"The Efficacy of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery.","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2023-06-21","conditions":"Post-mastectomy Pain Syndrome","enrollment":90},{"nctId":"NCT06261801","phase":"NA","title":"Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol","status":"RECRUITING","sponsor":"The Third People's Hospital of Hangzhou","startDate":"2024-02-07","conditions":"Trigeminal Herpetic Neuralgia","enrollment":102},{"nctId":"NCT04322305","phase":"PHASE2","title":"Pregabalin Trial for the Treatment of Alcohol Use Disorder","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2021-01-11","conditions":"Alcohol Use Disorder","enrollment":50},{"nctId":"NCT05150795","phase":"EARLY_PHASE1","title":"Effect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Post Operative Pain, Acute","enrollment":80},{"nctId":"NCT03928093","phase":"PHASE3","title":"Pregabalin Treatment for RDEB Pain and Itch","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2019-08-07","conditions":"Pain, Neuropathic, Itch, Epidermolysis Bullosa","enrollment":1},{"nctId":"NCT05640479","phase":"PHASE4","title":"Pregabalin Versus Dexmedetomidine for Delirium Prevention After Cardiac Surgery","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-15","conditions":"Pregabalin, Dexmedetomidine, Delirium","enrollment":60},{"nctId":"NCT06512155","phase":"PHASE1","title":"Improving Perioperative Sleep Disorders","status":"COMPLETED","sponsor":"Mengchang Yang","startDate":"2024-07-02","conditions":"Sleep Disorder","enrollment":215},{"nctId":"NCT05389150","phase":"PHASE1","title":"Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2019-01-17","conditions":"Healthy","enrollment":30},{"nctId":"NCT01480765","phase":"PHASE4","title":"Preventing Pain After Heart Surgery","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2011-12-12","conditions":"Pain, Hyperalgesia, Chronic Illness","enrollment":150},{"nctId":"NCT03797560","phase":"NA","title":"Comparison of Ba-Duan-Jin and Pregabalin in Patients with Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-22","conditions":"Fibromyalgia","enrollment":104},{"nctId":"NCT03890133","phase":"NA","title":"Exploration the Mechanism of Ba-Duan-Jin Therapy in the Management of Fibromyalgia","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-04-01","conditions":"Fibromyalgia","enrollment":60},{"nctId":"NCT05804591","phase":"PHASE4","title":"Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2023-04-24","conditions":"Obesity, Postoperative Pain, Postoperative Nausea and Vomiting","enrollment":90},{"nctId":"NCT04218240","phase":"PHASE2","title":"Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-12-17","conditions":"Opioid Withdrawal","enrollment":90},{"nctId":"NCT05160493","phase":"PHASE2, PHASE3","title":"The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy.","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2021-12-20","conditions":"Chronic Postsurgical Pain","enrollment":246},{"nctId":"NCT05795478","phase":"NA","title":"Effects of Oxycodone Combined With Pregabalin on Chronic Postsurgical Pain in Spinal Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-10-24","conditions":"Chronic Post Operative Pain, Oxycodone, Pregabalin","enrollment":264},{"nctId":"NCT06490484","phase":"PHASE2","title":"Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin","status":"RECRUITING","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2024-04-19","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":90},{"nctId":"NCT06077786","phase":"PHASE1","title":"A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2023-10-13","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT05598905","phase":"PHASE4","title":"Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2022-10-10","conditions":"Opioid-induced Respiratory Depression","enrollment":24},{"nctId":"NCT06221241","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain","status":"RECRUITING","sponsor":"Jemincare","startDate":"2024-03-25","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":220},{"nctId":"NCT06300346","phase":"NA","title":"Comparison Between Drugs for Control of Emetic Attacks During Caesarean Delivery","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2024-03-01","conditions":"Emetic Attacks During Caesarean Delivery With Spinal Anesthesia","enrollment":90},{"nctId":"NCT06187922","phase":"PHASE4","title":"Effect of Perioperative Oral Pregabalin in Total Knee Replacement","status":"UNKNOWN","sponsor":"Bahrain Defence Force Hospital","startDate":"2023-09-01","conditions":"Postoperative Pain","enrollment":120},{"nctId":"NCT05763550","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2023-02-27","conditions":"Herpetic Neuralgia","enrollment":331},{"nctId":"NCT06117917","phase":"PHASE2, PHASE3","title":"Esketamine Combined With Pregabalin on CPSP in Spinal Patients.","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2023-11-10","conditions":"Esketamine, Pregabaline, Chronic Post Operative Pain","enrollment":150},{"nctId":"NCT05624853","phase":"PHASE4","title":"A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2020-05-12","conditions":"Neuropathic Pain, Diabetes Mellitus, Type 2","enrollment":130},{"nctId":"NCT01773993","phase":"","title":"Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-02","conditions":"Pain Associated With Fibromyalgia","enrollment":534},{"nctId":"NCT01279850","phase":"","title":"Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-08","conditions":"Neuropathic Pain","enrollment":891},{"nctId":"NCT01256593","phase":"","title":"Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-02-05","conditions":"Neuralgia","enrollment":3827},{"nctId":"NCT05096468","phase":"PHASE2, PHASE3","title":"Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2021-12-01","conditions":"Esketamine, Pregabalin, Acute Postoperative Pain","enrollment":90},{"nctId":"NCT05324059","phase":"PHASE3","title":"Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2022-07-11","conditions":"Neuropathic Pain","enrollment":110},{"nctId":"NCT04161027","phase":"PHASE3","title":"RCT for Pregabalin in Restless Legs Syndrome in South Korea","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-02-24","conditions":"Restless Legs Syndrome","enrollment":116},{"nctId":"NCT04641273","phase":"PHASE2","title":"A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain","status":"TERMINATED","sponsor":"Bayer","startDate":"2021-01-22","conditions":"Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","enrollment":154},{"nctId":"NCT05547659","phase":"PHASE1, PHASE2","title":"Multimodal and Unimodal Analgesia in Cholecystectomy","status":"COMPLETED","sponsor":"October 6 University","startDate":"2019-01-01","conditions":"Compare Unimodal and Multimodal Analgesics","enrollment":95},{"nctId":"NCT04517110","phase":"PHASE3","title":"Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery","status":"TERMINATED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2021-04-09","conditions":"Opioid Use","enrollment":17},{"nctId":"NCT05529004","phase":"PHASE2","title":"A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy","status":"UNKNOWN","sponsor":"Al Safwa University College","startDate":"2022-09","conditions":"Postoperative Nausea and Vomiting","enrollment":100},{"nctId":"NCT05478382","phase":"PHASE4","title":"Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects","status":"UNKNOWN","sponsor":"Ajou University School of Medicine","startDate":"2022-10","conditions":"Postoperative Pain, Pregabalin, Spine Surgery","enrollment":132},{"nctId":"NCT05455944","phase":"NA","title":"Analgesic Efficacy of Pre-operative Oral Pregabalin in Dacryocystorhinostomy Surgery","status":"COMPLETED","sponsor":"Sameh Fathy","startDate":"2020-01-01","conditions":"Dacryocystitis","enrollment":100},{"nctId":"NCT01366196","phase":"NA","title":"Pregabalin for the Treatment of Pain After Posterior Spinal Fusions","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2008-10","conditions":"Lumbar Spinal Fusions","enrollment":86},{"nctId":"NCT04246619","phase":"PHASE4","title":"Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life","status":"TERMINATED","sponsor":"KRKA","startDate":"2019-11-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":254},{"nctId":"NCT05248152","phase":"NA","title":"Effect of Psychosocial and Psychophysical Factors and Preemptive Analgesia on Postoperative Pain in Upper Limb Surgery","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2022-01-13","conditions":"Postoperative Pain","enrollment":90},{"nctId":"NCT05071118","phase":"PHASE4","title":"The Efficacy of Pregabalin on the Duration of the Spinal Anesthesia and the Early Postoperative Pain After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-03-21","conditions":"Anesthesia","enrollment":70},{"nctId":"NCT02678117","phase":"PHASE3","title":"Analgesic Potentials of Preoperative Pregabalin,Magnesium Sulphate and Their Combination in Acute Post-thoracotomy Pain","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2015-07","conditions":"Postoperative Pain","enrollment":120},{"nctId":"NCT04708353","phase":"NA","title":"Oral Pregabalin Premedication for Postoperative Pain Relief","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2020-08-20","conditions":"Gynecologic Disease","enrollment":90},{"nctId":"NCT03348735","phase":"PHASE4","title":"Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment","status":"TERMINATED","sponsor":"University Hospital, Antwerp","startDate":"2018-12-03","conditions":"Neuropathic Pain","enrollment":33},{"nctId":"NCT00646451","phase":"EARLY_PHASE1","title":"Pregabalin in the Treatment of Essential Tremor","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2006-06","conditions":"Essential Tremor","enrollment":20},{"nctId":"NCT04847245","phase":"NA","title":"Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder","status":"UNKNOWN","sponsor":"Peking University","startDate":"2021-05-01","conditions":"Chronic Visceral Pain, Major Depressive Disorder","enrollment":80},{"nctId":"NCT03927781","phase":"PHASE3","title":"Perioperative Pregabalin in Ureteroscopy: a Pilot","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2019-04-01","conditions":"Nephrolithiasis, Urolithiasis, Perioperative/Postoperative Complications","enrollment":10},{"nctId":"NCT00991276","phase":"PHASE3","title":"Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-12","conditions":"Restless Legs Syndrome","enrollment":85},{"nctId":"NCT00676403","phase":"PHASE2","title":"Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-04","conditions":"Restless Legs Syndrome","enrollment":137},{"nctId":"NCT00843284","phase":"","title":"Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-09","conditions":"Neuropathic Pain","enrollment":691},{"nctId":"NCT00654940","phase":"PHASE1","title":"A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-05","conditions":"Nerve Pain","enrollment":25},{"nctId":"NCT04622202","phase":"PHASE1, PHASE2","title":"Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2020-11-15","conditions":"Anxiety State, Sedation","enrollment":74},{"nctId":"NCT01789216","phase":"PHASE3","title":"Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2013-07","conditions":"Orthopaedic Fractures","enrollment":450},{"nctId":"NCT01080612","phase":"PHASE1","title":"A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-04","conditions":"Healthy","enrollment":24},{"nctId":"NCT01020474","phase":"PHASE4","title":"Adolescent Fibromyalgia Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-05","conditions":"Fibromyalgia","enrollment":107},{"nctId":"NCT01020526","phase":"PHASE4","title":"Pregabalin In Adolescent Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-09","conditions":"Fibromyalgia","enrollment":63},{"nctId":"NCT01387607","phase":"PHASE3","title":"A Study For Pregabalin In Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-02-06","conditions":"Fibromyalgia","enrollment":343},{"nctId":"NCT01455428","phase":"PHASE4","title":"Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-12","conditions":"Postherpetic Neuralgia ( PHN )","enrollment":223},{"nctId":"NCT01474772","phase":"PHASE3","title":"Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-10","conditions":"Diabetic Peripheral Neuropathy","enrollment":217},{"nctId":"NCT01332149","phase":"PHASE3","title":"Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-07","conditions":"Diabetic Neuropathy, Painful","enrollment":626},{"nctId":"NCT01701362","phase":"PHASE3","title":"Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-10","conditions":"Neuropathic Pain","enrollment":542},{"nctId":"NCT01202227","phase":"PHASE3","title":"An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-09","conditions":"Spinal Cord Diseases, Spinal Cord Injuries, Neuralgia","enrollment":104},{"nctId":"NCT00883740","phase":"PHASE3","title":"Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-06","conditions":"Fibromyalgia, Sleep Disorders","enrollment":119},{"nctId":"NCT00629681","phase":"PHASE4","title":"A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-11","conditions":"Painful Diabetic Neuropathy and Post Herpetic Neuralgia","enrollment":217},{"nctId":"NCT00645398","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-09","conditions":"Fibromyalgia","enrollment":751},{"nctId":"NCT00978341","phase":"NA","title":"Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-02","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT00407745","phase":"PHASE3","title":"A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-01","conditions":"Neuralgia, Spinal Cord Injuries","enrollment":220},{"nctId":"NCT00760474","phase":"PHASE1","title":"An fMRI Study Of Brain Response In Patients With Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-01","conditions":"Fibromyalgia","enrollment":27},{"nctId":"NCT01291524","phase":"PHASE1","title":"Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-02","conditions":"Healthy","enrollment":24},{"nctId":"NCT01432236","phase":"PHASE3","title":"A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-10","conditions":"Fibromyalgia","enrollment":197},{"nctId":"NCT00288639","phase":"PHASE4","title":"Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Epilepsy","enrollment":98},{"nctId":"NCT01202422","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-10","conditions":"Healthy","enrollment":24},{"nctId":"NCT01321671","phase":"PHASE1","title":"Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-04","conditions":"Healthy","enrollment":24},{"nctId":"NCT00631943","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-11","conditions":"Neuralgia","enrollment":112},{"nctId":"NCT01270815","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-03","conditions":"Healthy","enrollment":28},{"nctId":"NCT01257516","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-02","conditions":"Healthy","enrollment":18},{"nctId":"NCT01257529","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-03","conditions":"Healthy","enrollment":28},{"nctId":"NCT01202435","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-10","conditions":"Healthy","enrollment":18}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"CELLULITIS"},{"count":3,"reaction":"DYSPNOEA"},{"count":3,"reaction":"HEADACHE"},{"count":3,"reaction":"NAUSEA"},{"count":3,"reaction":"OEDEMA"},{"count":2,"reaction":"COUGH"},{"count":2,"reaction":"DISEASE PROGRESSION"},{"count":2,"reaction":"DIZZINESS"},{"count":2,"reaction":"FLUSHING"},{"count":2,"reaction":"MALAISE"}],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["pregabalin","GPG","Lyrica","placebo (for pregablin)"],"phase":"marketed","status":"active","brandName":"Pregabalin capsule","genericName":"Pregabalin capsule","companyName":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","companyId":"guang-anmen-hospital-of-china-academy-of-chinese-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters. Used for Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury pain), Partial-onset seizures (adjunctive therapy), Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}